PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Timing of Delivery in Women with Cardiac Disease. Am J Perinatol. 2020 Dec 22. View abstract
  2. Intraperitoneal corticosteroids for recurrent ascites in patients with Fontan circulation: Initial clinical experience. J Card Surg. 2021 Feb; 36(2):735-738. View abstract
  3. Cardiovascular outcomes of pregnancy in Turner syndrome. Heart. 2021 Jan; 107(1):61-66. View abstract
  4. Assessment and management of heart failure in the systemic right ventricle. Heart Fail Rev. 2020 07; 25(4):609-621. View abstract
  5. Surveillance and screening practices of New England congenital cardiologists for patients after the Fontan operation. Congenit Heart Dis. 2019 Nov; 14(6):1013-1023. View abstract
  6. Hemodynamic Effects of Paracentesis in a Patient With a Fontan Circulation. World J Pediatr Congenit Heart Surg. 2019 05; 10(3):357-359. View abstract
  7. Relationship of Red Cell Distribution Width to Adverse Outcomes in Adults With Congenital Heart Disease (from the Boston Adult Congenital Heart Biobank). Am J Cardiol. 2018 11 01; 122(9):1557-1564. View abstract
  8. A Pilot Study of Inspiratory Muscle Training to Improve Exercise Capacity in Patients with Fontan Physiology. Semin Thorac Cardiovasc Surg. 2018 Winter; 30(4):462-469. View abstract
  9. Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation. 2017 Nov 14; 136(20):e348-e392. View abstract
  10. Liver health in adults with Fontan circulation: A multicenter cross-sectional study. J Thorac Cardiovasc Surg. 2017 03; 153(3):656-664. View abstract
  11. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients. J Heart Lung Transplant. 2017 Feb; 36(2):211-219. View abstract
  12. Clinical Approaches to the Patient with a Failing Fontan Procedure. Curr Cardiol Rep. 2016 May; 18(5):44. View abstract
  13. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation. J Am Heart Assoc. 2016 Jan 11; 5(1). View abstract
  14. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015 Jul; 34(7):883-91. View abstract
  15. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease. J Clin Endocrinol Metab. 2015 Apr; 100(4):1325-34. View abstract
  16. Exercise oscillatory ventilation in patients with Fontan physiology. Circ Heart Fail. 2015 Mar; 8(2):304-11. View abstract
  17. Rare case of undiagnosed supracardiac total anomalous pulmonary venous return in an adult. Circulation. 2014 Sep 30; 130(14):1205-7. View abstract
  18. Inadequate venous return as a primary cause for Fontan circulatory limitation. J Heart Lung Transplant. 2014 Nov; 33(11):1194-6. View abstract
  19. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. . 2014 Jul 01; 307(1):H110-7. View abstract
  20. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014 Sep-Oct; 9(5):438-47. View abstract
  21. Outcomes of adolescents and adults undergoing primary Fontan procedure. Am J Cardiol. 2013 Dec 15; 112(12):1938-42. View abstract
  22. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013 Apr; 99(7):491-6. View abstract
  23. Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. Int J Cardiol. 2013 Sep 01; 167(5):1918-23. View abstract
  24. Liver disease in the patient with Fontan circulation. Congenit Heart Dis. 2011 May-Jun; 6(3):190-201. View abstract
  25. Images in clinical medicine. Colonic saccular diverticula. N Engl J Med. 2008 Sep 18; 359(12):e13. View abstract
  26. Extrapericardial cardiac compression syndrome. Int J Cardiol. 2006 Nov 10; 113(2):285-7. View abstract